Graduate Students

��ñ�� Cares: Let’s talk about aging parents

admin — Fri, 05 Sep 2025 19:27:43 +0000

Join us on October 15, 2025 at noon for our next episode of ��ñ�� Cares, a webcast series designed to support informal caregivers.

Heterogeneity in human immune aging and vaccine responses

admin — Fri, 05 Sep 2025 18:34:14 +0000

Joint MIMM/Department of Medicine Seminar in Human Immunology
Speaker: Dr. Duygu Ucar
Title: "Heterogeneity in human immune aging and vaccine responses"

Monoclonal Antibody Discovery: Technologies and Applications

admin — Fri, 05 Sep 2025 18:40:17 +0000

Speaker: Dr. Ivelin Georgiev
Joint MIMM/Department of Medicine Seminar in Human Immunology
Title: "Monoclonal Antibody Discovery: Technologies and Applications"

Online Info Session: Graduate Certificate in Healthcare Management (GCHM)

admin — Fri, 05 Sep 2025 17:48:02 +0000

Discover the 8-month, 4-module, 100% online ��ñ�� Graduate Certificate in Healthcare Management at our Online Information Session.

Online Info Session: Graduate Certificate in Healthcare Management (GCHM)

admin — Fri, 05 Sep 2025 17:48:46 +0000

Discover the 8-month, 4-module, 100% online ��ñ�� Graduate Certificate in Healthcare Management at our Online Information Session.

Online Info Session: Graduate Certificate in Healthcare Management (GCHM)

admin — Fri, 05 Sep 2025 17:49:07 +0000

Discover the 8-month, 4-module, 100% online ��ñ�� Graduate Certificate in Healthcare Management at our Online Information Session.

Online Info Session: Graduate Certificate in Healthcare Management (GCHM)

admin — Fri, 05 Sep 2025 17:49:39 +0000

Discover the 8-month, 4-module, 100% online ��ñ�� Graduate Certificate in Healthcare Management at our Online Information Session.

Neuro Epilepsy Lecture Series: The Neurophysiological Basis of Internal Attention

admin — Fri, 05 Sep 2025 13:36:41 +0000

The 2024-2025 Neuro Epilepsy Lecture Series will include eight lectures covering hot topics in basic and clinical epilepsy research.

Latest Alzheimer’s drug shown less effective in females than males

admin — Tue, 18 Mar 2025 18:27:46 +0000

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.

Alan Evans receives Order of Canada

admin — Mon, 30 Jun 2025 21:35:08 +0000

Career of breakthroughs in neuroimaging recognized with one of the nation’s highest honours

A career that took an uncharted trajectory has been recognized with the Order of Canada, one of the country’s top honours.

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

admin — Tue, 25 Mar 2025 18:37:02 +0000

Free, online training program strengthens training and brings specialized care to communities across Quebec

A healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub. Under the direction of Julie Scorah, PhD, this milestone ensures that specialized knowledge reaches underserved communities.

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

admin — Fri, 14 Mar 2025 13:09:39 +0000

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.

Project to create AI model for ALS receives Génome Québec funding

admin — Mon, 17 Mar 2025 15:29:17 +0000

$400,000 will fuel public-private collaboration to discover new disease biomarkers

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

AI analysis of healthcare records reveals key factors in autism diagnosis

admin — Wed, 26 Mar 2025 15:23:21 +0000

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Human instruction with artificial intelligence guidance provided best results in neurosurgical training

admin — Wed, 06 Aug 2025 15:14:02 +0000

Study has implications beyond medical education, suggesting other fields could benefit from AI-enhanced training

Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction.